Elafibranor

Overview

Elafibranor is a dual PPARα/δ agonist. Elafibranor increases plasma HDL and expression of Acox1, a PPARα target gene, and decreases plasma triglycerides and total cholesterol in the liver of ApoE2-KI wild-type mice. Elafibranor is identified as a drug candidate for the treatment of cardiometabolic diseases such as diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD).

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cardiovascular and blood system | PPAR

Product Information

• Catalog No.: B0084-074234
• CAS No.: 923978-27-2
• Molecular Formula: C22H24O4S
• Molecular Weight: 384.49
• Purity: 98%
• Storage: Store at -20°C
• Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)

Source

Original product source